![]() | |
| 公司名 | BOC Sciences |
| 联系人 | Linna Green |
| 电 话 | +16314854226 |
| 手 机 | +16314854226 |
| 电子邮件 | info@bocsci.com |
| 网 址 | http://www.bocsci.com/ |
| 地 区 | 其他 |
| 邮 编 | 11967 |
在线询盘仅适合非紧急采购的情形,您需要留下收货地域,采购数量及联系方式。供应商在收到您的询盘信息后,会通过您留下的联系方式联络您。如果您希望立即和供应商交谈,请直接拨打供应商电话。供应商手机:+16314854226
| 中文名 | Nepicastat (SYN-117) HCl |
| 英文名 | Nepicastat (SYN-117) HCl |
| 别名 | 内匹司他盐酸盐;(S)-5-(氨基甲基)-1-(5,7-二氟-1,2,3,4-四氢萘-2-基)-1H-咪唑-2(3H)-硫酮盐酸盐 |
| CAS | 170151-24-3 |
| EINECS | |
| 化学式 | C14H15F2N3S·HCl |
| 分子量 | 331.81 |
| inchi | |
| 包装信息 | 50 mg |
| 价格 | $199 |
| 产品描述 | Nepicastat (SYN-117) HCl Nepicastat hydrochloride (SYN117, RS-25560-197) is an inhibitor of dopamine beta-hydroxylase that catalyzes the conversion of dopamine to norepinephrine. Nepicastat hydrochloride shows the selective and concentration-dependent inhibition effects on bovine and human dopamine-beta-hydroxylase activity in vitro. In vivo, Nepicastat hydrochloride increases dopamine content and dopamine/noradrenaline ratio in a dose-dependent manner. Nepicastat hydrochloride also produces the similar effects on noradrenaline, dopamine and dopamine/noradrenaline ratio in tissues and plasma of beagle dogs. Nepicastat is currently in Phase II clinical trials in patients with Posttraumatic Stress Disorder. |
| 产品链接 | http://www.bocsci.com/nepicastat-hcl-cas-170151-24-3-item-453616.html |
| 更新日期 | 2025-04-30 11:27:47 |